{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:26:38Z","timestamp":1781933198207,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Simulation Plus"},{"name":"Drug Development and Innovation Centre of the University of Alberta"},{"DOI":"10.13039\/501100004242","name":"Princess Nora Bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejpb.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T11:02:35Z","timestamp":1451732555000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Disease specific modeling: Simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-7591","authenticated-orcid":false,"given":"May","family":"Almukainzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhreddin","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aghazadeh-Habashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimar","family":"L\u00f6benberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9610(96)00048-7","article-title":"Delayed gastric emptying after gastric surgery","volume":"172","author":"Bar-Natan","year":"1996","journal-title":"Am. J. Surg."},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson\u2019s disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.12.004_b0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2125.1999.00902.x","article-title":"Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery","volume":"47","author":"Jamali","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.12.004_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5414\/CPP46055","article-title":"Rapidly dissolving formulations for quick absorption during pain episodes: ibuprofen","volume":"46","author":"Jamali","year":"2008","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejpb.2015.12.004_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bja\/56.2.161","article-title":"Gastric emptying and drug absorption before surgery","volume":"56","author":"Marsh","year":"1984","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.ejpb.2015.12.004_b0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ejpb.2008.07.013","article-title":"Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations","volume":"70","author":"Aghazadeh-Habashi","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2013.08.013","article-title":"Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain","volume":"155","author":"Moore","year":"2014","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ejpb.2015.12.004_b0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1124\/dmd.107.015644","article-title":"Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs","volume":"35","author":"De Buck","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2015.12.004_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0928-0987(02)00132-X","article-title":"Prediction of intestinal absorption: comparative assessment of GASTROPLUS\u2122 and IDEA\u2122","volume":"17","author":"Parrott","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2008.10.019","article-title":"Computer simulations using GastroPlus\u2122 to justify a biowaiver for etoricoxib solid oral drug products","volume":"72","author":"Okumu","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2015.12.004_b0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 1(0)","key":"10.1016\/j.ejpb.2015.12.004_b0060","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Adv. Drug Delivery Rev."},{"issue":"12","key":"10.1016\/j.ejpb.2015.12.004_b0065","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1007\/s11095-008-9642-z","article-title":"Dynamic dissolution testing to establish in vitro\/in vivo correlations for montelukast sodium, a poorly soluble drug","volume":"25","author":"Okumu","year":"2008","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2015.12.004_b0070","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1208\/s12249-013-0016-4","article-title":"In vitro\u2013in vivo correlation of efavirenz tablets using GastroPlus\u00ae","volume":"14","author":"Hon\u00f3rio","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2015.12.004_b0075","unstructured":"EMA, Guideline on the Investigation of Bioequivalence, Committee for Medicinal Products for Human Use, European Medicines Agency, 2010 (cited 2015)."},{"key":"10.1016\/j.ejpb.2015.12.004_b0080","unstructured":"FDA, Program of Physiologically-based Pharmacokinetic and Pharmacodynamic Modeling (PBPK Program), FDA 2014. <http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/ucm365118.htm> (cited 2015)."},{"key":"10.1016\/j.ejpb.2015.12.004_b0085","unstructured":"M.B. Bolger et al., GastroPlus PBPK\/PD Model Applied to Estimating Dose for an Elderly Population in an Alzheimer\u2019s Disease Clinical Trial, 2012."},{"key":"10.1016\/j.ejpb.2015.12.004_b0090","unstructured":"J. Macwan, Model-Based Approaches to Characterize Clinical Pharmacokinetics of Atorvastatin and Rosuvastatin in Disease State, Open Access Dissertations, 2013, p. 28."},{"issue":"6","key":"10.1016\/j.ejpb.2015.12.004_b0095","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1248\/bpb.22.616","article-title":"Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers","volume":"22","author":"Aiba","year":"1999","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejpb.2015.12.004_b0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cbpc.2007.01.020","article-title":"Comparative plasma pharmacokinetics of meloxicam in sheep and goats following intravenous administration","volume":"145","author":"Shukla","year":"2007","journal-title":"Comp. Biochem. Physiol., C \u2013 Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2015.12.004_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/chir.530020303","article-title":"Stereoselective disposition of ibuprofen and flurbiprofen in rats","volume":"2","author":"Knihinicki","year":"1990","journal-title":"Chirality"},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1389200013338810","article-title":"Pharmacology of chiral compounds: 2-arylpropionic acid derivatives","volume":"2","author":"Landoni","year":"2001","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstr\u00f6m","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2015.12.004_b0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2015.12.004_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/204925","article-title":"Evaluation of the DDSolver software applications","volume":"2014","author":"Zuo","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.ejpb.2015.12.004_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.ejpb.2015.12.004_b0135","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1011981317451","article-title":"Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats","volume":"15","author":"Chiou","year":"1998","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2015.12.004_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0b013e31827f7a3d","article-title":"Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children","volume":"56","author":"Devanarayana","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.ejpb.2015.12.004_b0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1208\/s12249-014-0241-5","article-title":"Simulation of in vitro dissolution behavior using DDDPlus\u2122","volume":"16","author":"Almukainzi","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.ejpb.2015.12.004_b0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","article-title":"Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children","volume":"45","author":"Johnson","year":"2006","journal-title":"Clin. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2015.12.004_b0155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-2125.2012.04363.x","article-title":"A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4","volume":"74","author":"Gaohua","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.12.004_b0160","first-page":"e3","article-title":"A PBPK model to predict disposition of CYP3A-metabolized drugs in pregnant women: verification and discerning the site of CYP3A induction","volume":"1","author":"Ke","year":"2012","journal-title":"CPT: Pharm. Syst. Pharmacol."},{"issue":"S1","key":"10.1016\/j.ejpb.2015.12.004_b0165","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1177\/0091270011415528","article-title":"Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation","volume":"52","author":"Zhao","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"25","key":"10.1016\/j.ejpb.2015.12.004_b0170","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1200\/JCO.2008.18.4390","article-title":"Inhibition of imatinib transport by uremic toxins during renal failure","volume":"26","author":"Franke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2015.12.004_b0175","first-page":"e148","article-title":"Physiologically based pharmacokinetic modeling and simulation in pediatric drug development","volume":"3","author":"Maharaj","year":"2014","journal-title":"CPT: Pharm. Syst. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.12.004_b0180","first-page":"353","article-title":"Modelling the absorption of metformin with patients post gastric bypass surgery","volume":"5","author":"Almukainzi","year":"2014","journal-title":"Diabetes Metab."},{"issue":"7","key":"10.1016\/j.ejpb.2015.12.004_b0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/03639045.2010.538058","article-title":"Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies","volume":"37","author":"Wilson","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2015.12.004_b0190","series-title":"Therapeutic Delivery Solutions","first-page":"335","article-title":"Biorelevant dissolution testing","author":"Almukainzi","year":"2014"},{"issue":"2","key":"10.1016\/j.ejpb.2015.12.004_b0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/ecp.10.143","article-title":"Modeling and predicting drug pharmacokinetics in patients with renal impairment","volume":"4","author":"Rowland Yeo","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2015.12.004_b0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.07.010","article-title":"Liposome formulation of poorly water soluble drugs: Optimisation of drug loading and ESEM analysis of stability","volume":"285","author":"Mohammed","year":"2004","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111500510X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111500510X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T07:52:33Z","timestamp":1537084353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111500510X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"alternative-id":["S093964111500510X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.12.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease specific modeling: Simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}